Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Article  PubMed  Google Scholar 

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S et al (2020) ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from national cancer registry program, India. JCO Glob Oncol 6:1063–1075

Article  PubMed  Google Scholar 

Bratan F et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019

Article  PubMed  Google Scholar 

Johnson DC et al (2019) Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging. Eur Urol 75:712

Article  CAS  PubMed  Google Scholar 

Weinreb JC et al (2016) PI-RADS prostate imaging—reporting and data system: 2015, version 2. Eur Urol 69:16

Article  PubMed  Google Scholar 

Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD (1994) Expression of the prostate specific membrane antigen. Cancer Res 54(7):1807–1811

CAS  PubMed  Google Scholar 

Corfield J et al (2018) (68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review. World J Urol 36:519

Article  PubMed  Google Scholar 

Stabile A, Pellegrino A, Mazzone E, Cannoletta D, de Angelis M, Barletta F, Scuderi S, Cucchiara V, Gandaglia G, Raggi D, Necchi A (2022) Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly diagnosed prostate cancer patients? A systematic review and meta-analysis with backup histology as reference standard. Eur Urol Oncol 5(1):1–7

Article  PubMed  Google Scholar 

Chen M, Zhang Q, Zhang C, Zhou YH, Zhao X, Fu Y, Gao J, Zhang B, Wang F, Qiu X et al (2020) Comparison of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer. Transl Androl Urol 9:382–390

Article  PubMed  PubMed Central  Google Scholar 

Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I et al (2016) Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer. Eur Urol 70(5):829–836

Article  CAS  PubMed  Google Scholar 

Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L (2018) Diagnostic accuracy of 68Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the detection of prostate cancer. Radiology 289(3):730–737

Article  PubMed  Google Scholar 

Muehlematter UJ, Burger IA, Becker AS, Schawkat K, Hötker AM, Reiner CS et al (2019) Diagnostic accuracy of multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for extracapsular extension and seminal vesicle invasion in patients with prostate cancer. Radiology 293(2):350–358

Article  PubMed  Google Scholar 

Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: the value of multiparametric MR imaging at 3 T for detection—histopathologic correlation. Radiology 255(1):89–99

Article  PubMed  PubMed Central  Google Scholar 

Perera M et al (2020) Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol 77:403

Article  PubMed  Google Scholar 

Woo S, Ghafoor S, Becker AS, Han S, Wibmer AG, Hricak H, Burger IA, Schöder H, Vargas HA (2020) Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis. Eur J Hybrid Imaging 4(1):1–15

Article  Google Scholar